Telix Pharmaceuticals Limited
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $1.16B
Liabilities Breakdown FY2025
Total Liabilities: $748.6M
Asset Breakdown
Total Assets: $1.16B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $141.9M | 12.2% |
| Accounts Receivable | $129.2M | 11.1% |
| Inventory | $37.1M | 3.2% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $199.0M | 17.1% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $656.9M | 56.4% |
Liabilities Breakdown
Total Liabilities: $748.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $150.3M | 20.1% |
| Long-Term Debt | $391.9M | 52.4% |
| Other Liabilities | $206.3M | 27.6% |